Workflow
生物制剂
icon
Search documents
安琪酵母拟投资建设智造中心;周六福港股上市;达能收购TAC
Sou Hu Cai Jing· 2025-06-29 15:20
Investment and Expansion - Angel Yeast plans to invest CNY 502 million to establish a biomanufacturing center, which will include a seven-story building with a total area of 27,687.65 square meters and an underground parking area for 297 vehicles [1][3] - The project is expected to enhance Angel Yeast's technological innovation capabilities in biomanufacturing, thereby strengthening its profitability and competitive edge [1][3] - Zhou Liufu, a jewelry company, successfully listed on the Hong Kong Stock Exchange, opening with a more than 10% increase and reaching a market capitalization of over HKD 10.5 billion [5] - Zhou Liufu's online sales are projected to grow at a compound annual growth rate of 46.1% from 2022 to 2024, with online sales expected to account for 40% of total revenue by 2024 [5] Market Position and Strategy - Ying Tong Holdings, the largest perfume brand management company in China, officially listed on the Hong Kong Stock Exchange, marking its strong market position [7] - The company is recognized as the third-largest perfume group in the comprehensive markets of mainland China, Hong Kong, and Macau, indicating its robust capability to enter the stock market [7] - Danone's acquisition of The Akkermansia Company aims to strengthen its investment in gut health and next-generation biological research, enhancing its core competitiveness in this field [11][13] - Dazzle Fashion Group announced the closure of all offline stores for its men's brand RAZZLE by August 31, 2025, focusing resources on its core mid-to-high-end women's wear business [16] Retail and Brand Development - HotMaxx's new store format, HotMaxx Super Warehouse, has opened in Beijing, featuring seven product zones while maintaining a low-price strategy [10] - Uniqlo plans to open its first store in southern India in Bangalore, marking a significant expansion into the southern market [18] Leadership Changes - The former business general manager of Kraft Heinz in China has joined Mondelēz as the head of the frozen cake team for Greater China, indicating a strategic focus on growth in the frozen baking sector [20] - Alibaba Group has streamlined its partner organization from 26 to 17 members, emphasizing a focus on frontline business leaders [22] - Anna Wintour announced her resignation as editor-in-chief of American Vogue while retaining her role as global editorial director, reflecting changes in the fashion media landscape [25]
冠菌素助力小麦单产提升,展示中国原创绿色农业力量
Huan Qiu Wang· 2025-06-03 08:09
【环球网财经综合报道】为深入推进粮油作物大面积单产提升行动,2025年5月30日至31日,由国家"十四五"重点研发计划支持的"新机制和新功能植物生长 调节剂创制与产业化"成果应用观摩会在商丘市夏邑县成功举办。 冠菌素的成功示范不仅是科研成果在实践中接受检验的重要节点,更是我国生物农业技术实现从实验室走向田间地头、实现"产—学—研—用"一体化协同落 地的生动范例。其作为国家重点研发计划支持下的原创调节剂技术成果,展现了我国在农业核心技术上的自立自强能力,为构建农用生物制剂的中国体系提 供了现实路径。 本次示范应用由全国农业技术推广服务中心技术指导,河南省植物保护植物检疫站和夏邑县农业农村局植保植检站实施完成。据悉,来自国家、省、市、县 各级农业技术体系的专家和一线农技人员近200人参与现场观摩交流,集中展示了项目核心成果——冠菌素在小麦抗逆增产中的应用成效。 在生物经济蓬勃发展的新时代背景下,冠菌素的应用推广将有助于推动传统农业走向绿色、高效、可持续的现代化新阶段。未来,相关单位将持续推进以冠 菌素为代表的绿色生物调节剂在更多主粮作物与主产区的示范推广,为我国农业绿色发展、化学农药减量替代和粮食安全保障提供坚实 ...
聚焦研发打造核心竞争力 蔚蓝生物2024年实现营收13.21亿元
本报讯 (记者刘钊)4月26日,青岛蔚蓝生物股份有限公司(以下简称"蔚蓝生物")同时发布2024年年 度报告及2025年一季度报告。数据显示,2024年年度,公司实现营收13.21亿元,同比增长10.16%,收 入规模稳步增长,实现净利润6263.75万元。2025年一季度,公司营收达3.10亿元,同比增长8.16%。 蔚蓝生物主要从事酶制剂、微生态制剂以及动物保健品的研发、生产和销售。公司以"生物科技还原生 态世界"为宗旨,致力于为生物制造提供核心技术支持,为传统产业提供清洁节能技术,为食品安全提 供绿色解决方案,全程服务农业、食品、洗涤、健康、环保、生物催化等多个产业。公司坚持技术创新 战略,持续加大研发投入,致力于打造以技术创新和全球化驱动的工业生物平台。 2024年,公司研发投入1.18亿元,占营业收入的8.95%,同比增长6.81%,在行业中处于较高水平。公司 持续优化价值客户的服务方案与运营效率,强化主业竞争力,并在全球化布局上深化"一带一路"产业布 局,推动国际市场拓展。 据悉,酶制剂、微生态制剂等生物行业是我国战略性新兴产业,具备高效、安全、节能、环保等特点, 是我国建设资源节约型、环境友好型 ...